Faculty profile

Gregory Knight

Back to faculty
Assistant Clinical Professor (Adjunct)OncologyMcMaster University

12 publications.

01

Surveillance evaluations in patients with stage I, II, III, or resectable IV melanoma who were treated with curative intent: A systematic review

Rajagopal S, Yao X, Abadir W, Baetz TD, Easson A, Knight G, McWhirter E, Nessim C, Rosen CF, Sun A

Surgical Oncology20246 citations
02

An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Surveillance Strategies in Patients with Stage I, II, III or Resectable IV Melanoma Who Were Treated with Curative Intent

Rajagopal S, Yao X, Abadir W, Baetz TD, Easson AM, Knight G, McWhirter E, Nessim C, Rosen CF, Sun A

Clinical Oncology20243 citations
03

Real-World Safety and Effectiveness of a Bevacizumab Biosimilar (ABP 215) in Metastatic Colorectal Cancer Patients in Canada

Cheung WY, Samimi S, Ma K, Knight GJ, Kassam S, Colwell B, Beaudoin A, Vincent MD, Trinkaus M, Filion A

Clinical Colorectal Cancer20243 citations
04

Restructuring Skin Cancer Care in Ontario: A Provincial Plan

Milkovich J, Hanna T, Nessim C, Petrella TM, Weatherhead L, Chan A-W, Irish JC, Murray C, Bannerman G, Holloway C

Current Oncology20214 citations
05

Systemic adjuvant therapy for adult patients at high risk for recurrent melanoma: A systematic review

Baetz TD, Fletcher GG, Knight G, McWhirter E, Rajagopal S, Song X, Petrella TM

Cancer Treatment Reviews202018 citations
06

Systemic adjuvant therapy for adult patients at high risk for recurrent cutaneous or mucosal melanoma: an Ontario Health (Cancer Care Ontario) clinical practice guideline

Petrella TM, Fletcher GG, Knight G, McWhirter E, Rajagopal S, Song X, Baetz TD

Current Oncology202016 citations
07

Staging and surgical approaches in gastric cancer: A systematic review

Coburn N, Cosby R, Klein L, Knight G, Malthaner R, Mamazza J, Mercer CD, Ringash J

Cancer Treatment Reviews2018111 citations
08

Staging and surgical approaches in gastric cancer: a clinical practice guideline.

Coburn N, Cosby R, Klein L, Knight G, Malthaner R, Mamazza J, Mercer CD, Ringash J

Current Oncology201743 citationsOpen Access
09

Impact of health care professional interventions on completion of therapy in patients receiving high-dose interferon-alfa 2b adjuvant therapy for high-risk melanoma.

Petrella TM, Tozer R, Knight GJ, Chang J, Pressnail BL, Rajagopal S, Gregorio N, Hamm CM, Cheng T, Smylie M

Journal of Clinical Oncology2014
10

Neoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and practice guideline for North America

Knight G, Earle CC, Cosby R, Coburn N, Youssef Y, Malthaner R, Wong RKS, The Gastrointestinal Cancer Disease Site Group

Gastric Cancer201351 citationsFirst author
Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for
Subject: Prospective PhD student Dear Professor Knight, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Surveillance evaluations in patients with stage I, II, III, or resectable IV melanoma who were treated with curative intent: A systematic review" (2024), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]
Open in email
Something wrong or missing on this profile? Suggest a correction